Bixiye
P67-17 PA Requirements for New Medicare Advantage Prescription Drug Products in 2018
Taariikhda uu dhaqangalayo Barnaamijka: Nov 06, 2017
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2951 - 2960 ee natiijooyinka 3167
Bixiye
P62-17 Addition of Drug to the Parathyroid Hormone Analog for Osteoporosis Prior Authorization with Quantity Limit Program
Taariikhda uu dhaqangalayo Barnaamijka: Nov 06, 2017
Bixiye
P64-17 New Drug-Related PA with Quantity Limit Criteria: Biologic Immunomodulators
Taariikhda uu dhaqangalayo Barnaamijka: Nov 06, 2017
Bixiye
P63-17 New Drug-Related PA with Quantity Limit Criteria: Otezla (apremilast)
Taariikhda uu dhaqangalayo Barnaamijka: Nov 06, 2017
Bixiye
P66-17 Clarification of Mid-Level Definitions
Taariikhda uu dhaqangalayo Barnaamijka: Nov 06, 2017
Bixiye
P61-17 FQHC/RHC Clinics Providing Interpreter Services for MHCP Subscribers
Taariikhda uu dhaqangalayo Barnaamijka: Nov 02, 2017
Bixiye
QP34-17 New Pre-Authorization Form for Immunoglobulin Therapy
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2017
Bixiye
P59-17 Government Programs Subscribers Prior Authorization Requirement for Spinal Fusion: Lumbar
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2017
Bixiye
P60-17 2018 Renewal Changes Summary for Institutional Providers
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2017
Bixiye
P19R1-17 New Remittance Code: OA-45 for Purchased/Referred (PRC)-Eligible Subscribers
Taariikhda uu dhaqangalayo barnaamijka: Okt 24, 2017